US Stem Cell is a biotechnology company focused on the discovery, development, and commercialization of cell therapies for the treatment of chronic and acute heart damage.
Company (IPO / Went public)
1560 Sawgrass Corporate Parkway
Florida, United States
|Investor||Investor Type||Location||Participating Rounds|
|Chapel Hill, North Carolina, United States||Acquired||Cardioxyl Pharmaceuticals is a privately held, clinical stage biopharmaceutical company developing therapies for the treatment of cardiovascular disease, focusing on the discovery, development and commercialization of technologies for disease areas where current therapies don't exist, are ineffective or are inadequate. Cardioxyl has developed solutions in the chemistry, biology and clinical applications of nitroxyl technology. The company's core nitroxyl platform has generated several pre-clinic...Show all||Login to see details|
|British Columbia, Canada||Alive / Active||Inflazyme Pharmaceuticals Ltd. is a biopharmaceutical company engaged in the discovery, development and commercialization of therapies for the treatment of respiratory and inflammatory diseases. The company's core focus is medicinal chemistry based, orally active, small molecules aimed at treating unmet medical needs.||Login to see details|